Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT04039594
NCT04039594RecruitingNot Applicable

Outcomes of Patients With Venoarterial Extracorporeal Membrane Oxygenation

Beijing Anzhen Hospital1 site in 1 country500 target enrollmentStarted: August 1, 2019Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
500
Locations
1
Primary Endpoint
All-cause mortality
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Venoarterial extracorporeal membrane oxygenation (VA ECMO)-also referred to as extracorporeal life support-is a form of temporary mechanical circulatory support and simultaneous extracorporeal gas exchange. The objective of this observational, cohort study is to evaluate the short-term and long-term outcomes of patients with VA ECMO.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients receiving VA ECMO for cardiopulmonary support

Exclusion Criteria

  • •Refusal of consent

Outcomes

Primary Outcomes

All-cause mortality

Time Frame: 30 days

Secondary Outcomes

  • ECMO-related complications(30 days)
  • Other complications(30 days)
  • All-cause mortality(365 days)
  • Rate of successful weaning from ECMO(30 days)
  • Duration stay at ICU and hospital(365 days)

Investigators

Sponsor
Beijing Anzhen Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Xiaotong Hou

Chief, Center for Cardiac Intensive Care

Beijing Anzhen Hospital

Study Sites (1)

Loading locations...

Similar Trials

Recruiting
Not Applicable
Outcomes of Veno Arterial ECMOMortalityExtra Corporeal Membrane Oxygenation
NCT05155904Centre Hospitalier Universitaire, Amiens150
Completed
Not Applicable
Vaso-inotropic Score and ECMO-VA Support in Post-cardiotomy Cardiogenic Shock.EMCO-VA
NCT05412303Centre Hospitalier Universitaire Dijon2,769
Recruiting
Not Applicable
Predictors of Mortality in Patients With VA-Extracorporeal Membrane Oxygenation.MoralityVA-ECMO
NCT05730894Hamad Medical Corporation120
Unknown
Not Applicable
Health-related Quality of Life in Adults After Veno-arterial Extra-Corporeal Membrane Oxygenation Which is a Salvage Therapy Used in Patients With Severe Respiratory or Cardiac Failure Who Have Not Responded to Maximal Conventional Medical TherapyVeno-arterial Extra-Corporeal Membrane OxygenationHealth Related Quality of Life
NCT04653298University Hospital, Strasbourg, France300
Unknown
Not Applicable
Long-term Outcome of Patients Treated With Extracorporeal Membrane OxygenationLong-term OutcomeExtracorporeal Membrane Oxygenation
NCT03182023Southeast University, China83